Literature DB >> 26799528

The influence of initial mucosal thickness on crestal bone change in similar macrogeometrical implants: a prospective randomized clinical trial.

Paul van Eekeren1, Pieter van Elsas1, Ali Tahmaseb1, Daniel Wismeijer1.   

Abstract

OBJECTIVE: The objective of this study was to evaluate crestal bone changes around bone- and tissue-level implants related to initial mucosal thickness.
MATERIALS AND METHODS: Patients received at least 2 implants: one with the prosthetic abutment connection at the crestal bone level (MC) and one with the prosthetic abutment connection at 2.5 mm supra crestal (LC). Flap thickness measurements were taken using a periodontal probe after raising the buccal flap. Patients were divided into 2 groups according to the mucosal thickness-Group A (thickness, ≤2 mm) and Group B (thickness, >2 mm).
RESULTS: Our study included 33 patients and 78 implants. Each patient received at least 1 implant of each type: Group A (MC), 17 implants, with a mean bone change of -0.6 ± 0.5 mm; Group B (MC), 20 with a mean bone change of -0.2 ± 0.4 mm; Group A (LC), 15 with a mean bone change of -0.1 ± 0.5 mm; and Group B (LC), 22 with a mean bone change of -0.2 ± 0.4 mm. A paired-samples t-test for groups A (MC) and B (MC) yielded a statistically significant difference (P = 0.003); there was no statistically significant difference for groups A (LC) and B (LC) (P = 0.518).
CONCLUSION: If the initial mucosal thickness surrounding bone-level implants is more than 2 mm, there is significantly less crestal bone change compared with bone-level implants placed in initial mucosal thicknesses of 2 mm or less. This difference is not statistically significant when tissue-level implants are used and the implant-abutment connection is 2.5 mm above the crestal bone level.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  bone implant interactions; soft tissue-implant interactions; wound healing

Mesh:

Substances:

Year:  2016        PMID: 26799528     DOI: 10.1111/clr.12784

Source DB:  PubMed          Journal:  Clin Oral Implants Res        ISSN: 0905-7161            Impact factor:   5.977


  6 in total

1.  Connective tissue graft versus xenogeneic collagen matrix for soft tissue augmentation at implant sites: a randomized-controlled clinical trial.

Authors:  Igor Ashurko; Svetlana Tarasenko; Aleksandr Esayan; Alexandr Kurkov; Karen Mikaelyan; Maxim Balyasin; Anna Galyas; Julia Kustova; Silvio Taschieri; Stefano Corbella
Journal:  Clin Oral Investig       Date:  2022-08-27       Impact factor: 3.606

2.  Variations in vertical mucosal thickness at edentulous ridge according to site and gender measured by cone-beam computed tomography.

Authors:  Motohiro Munakata; Koudai Nagata; Minoru Sanda; Ryota Kawamata; Daisuke Sato; Kikue Yamaguchi
Journal:  Int J Implant Dent       Date:  2021-05-12

3.  Comprehensive peri-implant tissue evaluation with ultrasonography and cone-beam computed tomography: A pilot study.

Authors:  Rafael Siqueira; Khaled Sinjab; Ying-Chun Pan; Fabiana Soki; Hsun-Liang Chan; Oliver Kripfgans
Journal:  Clin Oral Implants Res       Date:  2021-05-03       Impact factor: 5.021

4.  An evaluation of superhydrophilic surfaces of dental implants - a systematic review and meta-analysis.

Authors:  Arkadiusz Makowiecki; Jakub Hadzik; Artur Błaszczyszyn; Tomasz Gedrange; Marzena Dominiak
Journal:  BMC Oral Health       Date:  2019-05-10       Impact factor: 2.757

5.  Analysis of Prosthetic Factors Affecting Peri-Implant Health: An in vivo Retrospective Study.

Authors:  Reham N AlJasser; Mohammed A AlSarhan; Dalal H Alotaibi; Saleh AlOraini; Abdul Sadekh Ansari; Syed Rashid Habib; Muhammad Sohail Zafar
Journal:  J Multidiscip Healthc       Date:  2021-05-25

6.  Correlation between Buccal Bone Thickness at Implant Placement in Healed Sites and Buccal Soft Tissue Maturation Pattern: A Prospective Three-Year Study.

Authors:  Davide Farronato; Pietro Mario Pasini; Andrea Alain Orsina; Mattia Manfredini; Lorenzo Azzi; Marco Farronato
Journal:  Materials (Basel)       Date:  2020-01-21       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.